BIOMAT Database Logo BIOMAT Database Logo

Case of perforated peptic ulcer treated conservatively. 1994

H Nakamura, and H Kinoshita, and M Higashino, and K Hirohashi, and S Takehara, and T Shuto
Second Department of Surgery, Osaka City University Medical School, Japan.

We report a patient fifty-one-year old man with peptic ulcer which was treated conservatively. His chief complaints were epigastric discomfort and tarry stool. On admission, no fever was noted, the abdomen was flat and extremely hard, tenderness was noted, and peritoneal rebound was absent. Laboratory data on admission were all normal except for a slightly elevated CRP level. Oral intake was suspended and the patient received infusion. The chest X-ray film on the following day revealed free air, and the diagnosis of perforation of the upper digestive tract was confirmed; however, the symptoms and signs of peritonitis diminished. Therefore, he was treated conservatively. This case suggests that the conventional indications for emergency surgery for perforated peptic ulcer should be re-evaluated.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010289 Parenteral Nutrition, Total The delivery of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously, or by some other non-alimentary route. The basic components of TPN solutions are protein hydrolysates or free amino acid mixtures, monosaccharides, and electrolytes. Components are selected for their ability to reverse catabolism, promote anabolism, and build structural proteins. Hyperalimentation, Parenteral,Intravenous Hyperalimentation,Nutrition, Total Parenteral,Parenteral Hyperalimentation,Total Parenteral Nutrition,Hyperalimentation, Intravenous
D010439 Peptic Ulcer Perforation Penetration of a PEPTIC ULCER through the wall of DUODENUM or STOMACH allowing the leakage of luminal contents into the PERITONEAL CAVITY. Peptic Ulcer Perforations,Perforation, Peptic Ulcer,Perforations, Peptic Ulcer,Ulcer Perforation, Peptic,Ulcer Perforations, Peptic
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D006635 Histamine H2 Antagonists Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. Antihistaminics, H2,H2 Receptor Blockader,Histamine H2 Antagonist,Histamine H2 Blocker,Histamine H2 Receptor Antagonist,Histamine H2 Receptor Antagonists,Histamine H2 Receptor Blockader,Histamine H2 Receptor Blockaders,Antagonists, Histamine H2,Blockaders, Histamine H2 Receptor,H2 Receptor Blockaders,Histamine H2 Blockers,Receptor Antagonists, Histamine H2,Receptor Blockaders, H2,Antagonist, Histamine H2,Blockader, H2 Receptor,Blockaders, H2 Receptor,Blocker, Histamine H2,Blockers, Histamine H2,H2 Antagonist, Histamine,H2 Antagonists, Histamine,H2 Antihistaminics,H2 Blocker, Histamine,H2 Blockers, Histamine,Receptor Blockader, H2
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer

Related Publications

H Nakamura, and H Kinoshita, and M Higashino, and K Hirohashi, and S Takehara, and T Shuto
Perforated enteric ulcer successfully treated conservatively.
September 1949, Lancet (London, England),
H Nakamura, and H Kinoshita, and M Higashino, and K Hirohashi, and S Takehara, and T Shuto
Perforated acute duodenal ulcer can be treated conservatively.
January 1995, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology,
H Nakamura, and H Kinoshita, and M Higashino, and K Hirohashi, and S Takehara, and T Shuto
Perforated peptic ulcer treated without operation.
April 1947, Lancet (London, England),
H Nakamura, and H Kinoshita, and M Higashino, and K Hirohashi, and S Takehara, and T Shuto
Perforated peptic ulcer; treated without operation.
September 1946, Lancet (London, England),
H Nakamura, and H Kinoshita, and M Higashino, and K Hirohashi, and S Takehara, and T Shuto
A case of perforated peptic ulcer successfully treated without operation.
July 1951, Journal of the Indian Medical Association,
H Nakamura, and H Kinoshita, and M Higashino, and K Hirohashi, and S Takehara, and T Shuto
[Liver function in peptic ulcer treated surgically or conservatively].
July 1967, Polski tygodnik lekarski (Warsaw, Poland : 1960),
H Nakamura, and H Kinoshita, and M Higashino, and K Hirohashi, and S Takehara, and T Shuto
Perforated peptic ulcer.
October 1947, American practitioner and digest of treatment,
H Nakamura, and H Kinoshita, and M Higashino, and K Hirohashi, and S Takehara, and T Shuto
[Perforated peptic ulcer].
August 1955, El Dia medico,
H Nakamura, and H Kinoshita, and M Higashino, and K Hirohashi, and S Takehara, and T Shuto
PERFORATED PEPTIC ULCER.
June 1964, The Practitioner,
H Nakamura, and H Kinoshita, and M Higashino, and K Hirohashi, and S Takehara, and T Shuto
Perforated peptic ulcer.
October 1947, American practitioner and digest of treatment,
Copied contents to your clipboard!